Case number 1:21-cv-01522
Azurity Pharmaceuticals, Inc. v. CoreRx, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 29, 2021 | 7 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Nov 26, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (ntl) |
| Nov 26, 2021 | 6 | Notice (Other) (1) Docket Text: NOTICE of Dismissal Without Prejudice by Azurity Pharmaceuticals, Inc. (Dellinger, Megan) |
| Nov 3, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (nms) |
| Oct 27, 2021 | 1 | Complaint (Main Document) (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against CoreRx, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3730723.) - filed by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(myr) |
| Oct 27, 2021 | 1 | Complaint (Exhibit A-B) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against CoreRx, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3730723.) - filed by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(myr) |
| Oct 27, 2021 | 1 | Complaint (Civil Cover Sheet) (2) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against CoreRx, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3730723.) - filed by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(myr) |
| Oct 27, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Oct 27, 2021 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,040,023 B2 ;11,141,405 B2. (myr) |
| Oct 27, 2021 | 4 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc. (myr) |
| Oct 27, 2021 | 5 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to CoreRx, Inc. on 10/27/2021. (myr) |
